Center Eugene Marquis
36
9
10
18
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
4 terminated/withdrawn out of 36 trials
81.8%
-4.7% vs industry average
6%
2 trials in Phase 3/4
0%
0 of 18 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor
Role: lead
Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer
Role: lead
Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis
Role: lead
Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer
Role: lead
Prevention of Sequelae Pain After Breast Cancer Surgery by Self-massages and Self Stretching. Impact of Learning Workshops.
Role: lead
Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)
Role: lead
Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer
Role: lead
Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma
Role: lead
Systematic Intervention to Improve Sexual Dysfunction
Role: lead
Comparison of Humeral or Thoracic Implantation of an Central Veinous Access by an Implantable Venous Access Device in Patients With Solid Tumors Requiring Chemotherapy
Role: lead
Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer
Role: lead
Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy
Role: lead
Anticipated Personalization of the Management in Day Hospital Unit Based on a Collection of the PROs Via a Digital Tool
Role: lead
Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN
Role: collaborator
Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer
Role: lead
Evaluation of Music on the Level of Anxiety Felt During External Radiotherapy Sessions
Role: lead
Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma.
Role: lead
Accelerated Radio-Immunotherapy for Lung Cancer
Role: lead
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
Role: collaborator
Adaptative Radiotherapy for Locally Advanced Cervical Cancer
Role: lead